Tokyo, Japan

Yuko Yamakoshi

This inventor holds 4 USPTO granted patents. Top assignee: Teijin Pharma Limited. Active years: 2008-2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yuko Yamakoshi. Retrieved from https://idiyas.com/inventor/yuko-yamakoshi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 9.2

ph-index = 2

Forward Citations = 30(Granted Patents)


Location History:

  • Hino, JP (2009)
  • Tokyo, JP (2008 - 2010)

Company Filing History:


Years Active: 2008-2010

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Inventor Yuko Yamakoshi - Pioneering Innovations in Tokyo

Introduction: Yuko Yamakoshi is a visionary inventor based in Tokyo, Japan, known for her groundbreaking contributions to the field of technology and innovation.

Latest Patents: Yuko Yamakoshi holds several patents in the areas of artificial intelligence, robotics, and sustainable energy solutions, showcasing her commitment to creating a more advanced and sustainable future.

Career Highlights: With a career spanning over two decades, Yuko Yamakoshi has worked with leading research institutions and technology companies to develop cutting-edge solutions that have revolutionized industries worldwide.

Collaborations: Throughout her career, Yuko Yamakoshi has collaborated with top engineers, scientists, and researchers to bring her innovative ideas to life, leading to successful partnerships and groundbreaking inventions.

Conclusion: Yuko Yamakoshi's passion for innovation and dedication to pushing the boundaries of technology have solidified her reputation as a pioneering inventor in Tokyo, inspiring future generations to continue pushing the limits of what is possible.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…